Xenon Pharmaceuticals Ownership & Insider Activity

Xenon Pharmaceuticals (XENE) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.6% of shares outstanding. Institutional investors hold 68.1%. Over the past 90 days, insiders made 2 purchases worth $1.7M and 2 sales worth $1.1M.

Shares Outstanding

96.840M

Shares Float

96.731M

Insider Shares Owned

600.729K

Insider % Owned

0.6%

Institutional Shares Held

65.961M

Institutional % Held

68.1%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$1.7M total

Sales (90d)

$1.1M total

Net Activity

Net Buying

Net Value (90d)

$615K

Xenon Pharmaceuticals Insider Transactions (Last 6 Months)

모든 내부자 거래 내역 보기 →

Date	Insider	Title	Type	Shares	Price	Value
Sep 30, 2026	Patrick Thomas Kelly	CHIEF FINANCIAL OFFICER	BUY	15.000K	$37.32	$560K
Sep 30, 2026	IAN MORTIMER	PRESIDENT & CEO	BUY	30.000K	$37.38	$1.1M
Aug 28, 2026	JOHN CHRISTOPHER KENNEY	CHIEF MEDICAL OFFICER	SELL	7.068K	$60.25	$426K
Aug 11, 2026	STEVEN GANNON	—	SELL	10.000K	$64.06	$641K
Jun 5, 2026	GARY PATOU	—	SELL	1.322K	$53.14	$70K
Jun 5, 2026	Gillian Cannon	—	SELL	1.190K	$53.14	$63K

More with Benzinga EdgeGet Access

Xenon Pharmaceuticals Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Xenon Pharmaceuticals Ownership & Insider Activity

Xenon Pharmaceuticals Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch